Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer.

Article Details

Citation

Copy to clipboard

Hutson PR

Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer.

Clin Pharmacokinet. 2015 Oct;54(10):989-91. doi: 10.1007/s40262-015-0293-z.

PubMed ID

26077984 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Enzalutamide	Cytochrome P450 2B6	Protein	Humans	No	Inhibitor	Details